Lib’s Grill is one step closer to opening in downtown Sykesville’s historic Baltimore & Ohio Railroad train station building, after several years of delays. The town’s planning commission on Aug. 4 ...
LIB Therapeutics Inc. (LIB), a privately-held, biopharmaceutical company with a recently approved novel, monthly, small-dose, third-gene ...
The popular local family-run restaurant Liberatore’s and its more casual Lib’s Grill spinoff are opening more locations. John Liberatore announced that his namesake restaurant will “finally” be coming ...
CINCINNATI--(BUSINESS WIRE)--LIB Therapeutics Inc. (LIB), a late-stage biopharmaceutical company developing subcutaneous and oral PCSK9 inhibitor therapies for patients at very high and high-risk of ...
LIB Therapeutics has passed another milestone on its path to launching a challenger to cholesterol drugs sold by Amgen, Regeneron and Sanofi. In the latest phase 3 readout, the private biotech’s ...
Privately-held drug developer LIB Therapeutics has claimed FDA approval for a new once-monthly PCSK9 inhibitor – Lerochol – that can be used to reduce cholesterol levels. The injectable product has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results